WNX

Wellnex Life Limited

Retail First-pass screen £4.02m

360/1000 Overall fit

AI beneficiary 35% 25

Operating leverage 25% 50

Valuation 25% 30

Downside protection 15% 45

First-pass take

Consumer healthcare firm with strong revenue growth (+46%) and margin expansion (+55%), but no disclosed AI exposure. Critical gaps: zero valuation data, no profitability metrics, brief trading update only. Recent debt paydown ($13m) is positive but insufficient detail for confident assessment.

Flags

no-ai-exposureno-valuation-datamicro-capthin-docearly-stage-expansion